ANKRD22 enhances breast cancer cell malignancy by activating the Wnt/β-catenin pathway via modulating NuSAP1 expression. Biomol Biomed [Internet]. 2021 Jun. 1 [cited 2024 Apr. 29];21(3):294-30. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/4701